Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IYH
103
HOLDINGS
12%
ALSO IN CANC
CANC
52
HOLDINGS
23%
ALSO IN IYH
SECTOR DRIFT (IYH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.5% | 5.8% | 5.8% |
|
ABBVIE INC | 7.1% | 2.7% | 2.7% |
|
JOHNSON & JOHNSON | 8.2% | 2.2% | 2.2% |
|
GILEAD SCIENCES INC | 2.7% | 2.2% | 2.2% |
|
AMGEN INC | 3.1% | 1.9% | 1.9% |
IYH Overweight Relative to CANC
|
ELI LILLY & CO | 7.7% |
|
JOHNSON & JOHNSON | 6.0% |
|
UNITEDHEALTH GROUP INC | 5.4% |
|
ABBVIE INC | 4.4% |
|
ABBOTT LABORATORIES | 4.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
INTUITIVE SURGICAL INC | 3.6% |
|
MERCK & CO. INC. | 2.8% |
|
BOSTON SCIENTIFIC CORP | 2.7% |
|
PFIZER INC | 2.5% |
IYH Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.9% |
|
BRIDGEBIO PHARMA, INC. | -4.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
ASTRAZENECA PLC | -4.0% |
|
NOVARTIS AG | -4.0% |
 |
GENMAB A/S SPONSORED ADR | -3.9% |
|
ARCELLX, INC. | -3.7% |
|
NUVALENT, INC. CLASS A | -3.6% |
|
EXELIXIS INC | -2.9% |
|
IDEAYA BIOSCIENCES, INC. | -2.6% |